IMPORT HIGH trial: Dose escalated simultaneous integrated boost radiotherapy in early breast cancer

Autor: Coles, C, Haviland, JS, Kirby, AM, Bhattacharya, I, Brunt, AM, Chan, C, Donovan, EM, Eaton, DJ, Griffin, CL, Hopwood, P, Jefford, ML, Lightowlers, S, Rajapakse, C, Sawyer, E, Stones, L, Syndikus, I, Titley, JC, Tsang, Y, Twyman, NI, Bliss, JM, Yarnold, JR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::9bb21069d71a88c0e1c92e625ef55007

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.

Autor: Coles CE; Department of Oncology, University of Cambridge, Cambridge, UK. Electronic address: cec50@cam.ac.uk., Haviland JS; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK., Kirby AM; Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK., Griffin CL; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK., Sydenham MA; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK., Titley JC; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK., Bhattacharya I; Department of Oncology and Radiotherapy, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Brunt AM; School of Medicine, University of Keele, Keele, UK; University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK., Chan HYC; Department of Breast Surgery, Nuffield Health Cheltenham Hospital, Cheltenham, UK., Donovan EM; Centre for Vision, Speech and Signal Processing, University of Surrey, Guildford, UK., Eaton DJ; Department of Medical Physics, Guy's and St Thomas' Hospitals, London, UK., Emson M; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK., Hopwood P; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK., Jefford ML; Independent Cancer Patients Voice, London, UK., Lightowlers SV; Department of Oncology, University of Cambridge, Cambridge, UK., Sawyer EJ; Guy Cancer Centre School of Cancer and Pharmaceutical Sciences, Guy's and St Thomas' Foundation Trust, Kings College London, London, UK., Syndikus I; Department of Radiotherapy, Clatterbridge Cancer Centre, Bebington, UK., Tsang YM; Radiotherapy Trials QA Group, Mount Vernon Cancer Centre, Northwood, UK., Twyman NI; Department of Medical Physics, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Yarnold JR; Department of Radiotherapy and Imaging, Institute of Cancer Research, Sutton, UK., Bliss JM; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK.

Publikováno v: Lancet (London, England) [Lancet] 2023 Jun 24; Vol. 401 (10394), pp. 2124-2137. Date of Electronic Publication: 2023 Jun 08.